Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jun 1;199(11):1432.
doi: 10.1164/rccm.201806-1155IM.

Tyrosine Kinase Inhibitor-associated Fibrothorax

Andres M Adrianza  1 , Carlos A Jimenez  1 , Grecia L Aldana  1 , Leonardo Pozo  1 , Jorge E Cortes  2 , Ala Eddin S Sagar  1
Affiliations
Case Reports

Tyrosine Kinase Inhibitor-associated Fibrothorax

Andres M Adrianza et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Computed tomography scan of the chest demonstrating a left-side pleural effusion with pleural thickening (white arrows). (B) Left side pleural thickening on chest X-ray (white arrow). (C) Thick pleura after pleurectomy.
See this image and copyright information in PMC

References

    1. Bergeron A, Réa D, Levy V, Picard C, Meignin V, Tamburini J, et al. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. Am J Respir Crit Care Med. 2007;176:814–818. - PubMed
    1. Ferreiro L, San-José E, Suárez-Antelo J, Valdés L. Dasatinib-induced pleural effusion: chylothorax, an option to consider. Ann Thorac Med. 2016;11:289–293. - PMC - PubMed
    1. Ustun C, Randall N, Podgaetz E, Amin K, Dincer HE. Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor. Thorax. 2015;70:701–704. - PubMed

Publication types

MeSH terms